| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4077690
Max Phase: Preclinical
Molecular Formula: C18H16N2O4
Molecular Weight: 324.34
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: Cc1ccc(-c2cc(CC(=O)c3c(O)cc(O)cc3O)n[nH]2)cc1
Standard InChI: InChI=1S/C18H16N2O4/c1-10-2-4-11(5-3-10)14-6-12(19-20-14)7-15(22)18-16(23)8-13(21)9-17(18)24/h2-6,8-9,21,23-24H,7H2,1H3,(H,19,20)
Standard InChI Key: BQFZWZXDTCKJGW-UHFFFAOYSA-N
Associated Targets(non-human)
Prmt1 Protein arginine N-methyltransferase 1 (55 Activities)
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 324.34 | Molecular Weight (Monoisotopic): 324.1110 | AlogP: 2.93 | #Rotatable Bonds: 4 |
| Polar Surface Area: 106.44 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 4 |
| #RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 7.95 | CX Basic pKa: 2.19 | CX LogP: 4.53 | CX LogD: 4.42 |
| Aromatic Rings: 3 | Heavy Atoms: 24 | QED Weighted: 0.55 | Np Likeness Score: -0.39 |
References
| 1. Wang C, Jiang H, Jin J, Xie Y, Chen Z, Zhang H, Lian F, Liu YC, Zhang C, Ding H, Chen S, Zhang N, Zhang Y, Jiang H, Chen K, Ye F, Yao Z, Luo C.. (2017) Development of Potent Type I Protein Arginine Methyltransferase (PRMT) Inhibitors of Leukemia Cell Proliferation., 60 (21): [PMID:29019697] [10.1021/acs.jmedchem.7b01134] |
Source
Source(1):